Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.500
+0.020 (0.81%)
Nov 20, 2024, 4:00 PM EST - Market open
Nkarta Market Cap
Nkarta has a market cap or net worth of $176.42 million as of November 21, 2024. Its market cap has increased by 56.36% in one year.
Market Cap
176.42M
Enterprise Value
-21.18M
1-Year Change
56.36%
Ranking
Category
Stock Price
$2.50
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $176.42M, a decrease of -87.95%. That is a compound annual growth rate of -38.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 176.42M | -45.53% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | 2.00B | 36.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caribou Biosciences | 177.94M |
| Tenaya Therapeutics | 176.27M |
| Galectin Therapeutics | 176.05M |
| Inozyme Pharma | 175.38M |
| Actuate Therapeutics | 173.57M |
| Heron Therapeutics | 172.63M |
| Stereotaxis | 172.42M |
| Greenwich LifeSciences | 170.88M |